Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Pharmacotherapy: Treatment of Tuberculosis and Multidrug-Resistant Tuberculosis

Webinar/Podcast
Pharmacotherapy: Treatment of Tuberculosis and Multidrug-Resistant Tuberculosis

In this webinar, Dr. Charles Peloquin presents information on the epidemiology of TB in the US. Dr. Peloquin also discusses emerging treatments for latent TB infection and for active TB disease.

Author:

Southeastern National Tuberculosis Center, SNTC

Audiences:

Physicians, Nurses

Topic:

Treatment - Latent TB infection (Inactive TB), Treatment- Medication Information, Treatment- TB Disease

Country of Origin:

United States

View Webpage

Related Materials

Treatment of Multidrug-Resistant Tuberculosis (MDR-TB)

This MDR TB online course exists as a free self-learning online tool in allowing physicians worldwide to learn and test their knowledge of MDR TB. It is accredited by the South African Medical Association and the Norwegian Medical Association. The course contains seven modules and covers etiology and pathogenesis of TB, diagnosis and treatment, special situations, patient-physician communication, treatment adherence, and TB infection and control. A PDF version of the course is available in French, Spanish, Mandarin Chinese, and Azeri.

Training

Treatment of Multidrug-Resistant Tuberculosis (MDR-TB)

This Course is intended as an introduction to multidrug-resistant tuberculosis (MDR-TB) management, and is aimed at medical practitioners involved in the detection, management and treatment of MDR-TB patients, under the guiding principles of the World Health Organization's Stop TB Strategy. The Course aims to facilitate self-study by medical practitioners of contemporary, evidence-based standards for diagnosis and clinical management of MDR-TB in a variety of geographical, economic and social settings. The course does not include everything one needs to know to manage MDR-TB, but serves a good base for understanding the issues. MDR-TB treatment is a programmatic activity, and treatment of patients should preferably be conducted with expert consultation under guidance of National TB Control Programmes, in accordance with follow national guidelines. This course was developed with support from the Lilly MDR-TB Partnership and technical assistance from the New Jersey Medical School Global Tuberculosis Institute.

Training

Treatment of Multidrug-Resistant Tuberculosis (MDR-TB)

This application, created by the WMA and the New Jersey Medical School Global Tuberculosis Institute, gives physicians the flexibility to access the course material at any time, even when they are discussing treatment options with their patients. The application was developed in collaboration with the World Health Organization with financial support from the Eli Lilly MDR-TB partnership. The application contains the eight training modules which comprise the WMA's course on MDR-TB. It is intended as an introduction to MDR-TB management and is consistent with the principles of the WHO Stop TB Strategy.

Training

Global resources for the prevention,
management, and elimination of TB.